CN111760033A - Method for preparing beta-cyclodextrin and essential oil inclusion compound by alkaline electrolytic water method - Google Patents
Method for preparing beta-cyclodextrin and essential oil inclusion compound by alkaline electrolytic water method Download PDFInfo
- Publication number
- CN111760033A CN111760033A CN202010534051.8A CN202010534051A CN111760033A CN 111760033 A CN111760033 A CN 111760033A CN 202010534051 A CN202010534051 A CN 202010534051A CN 111760033 A CN111760033 A CN 111760033A
- Authority
- CN
- China
- Prior art keywords
- essential oil
- cyclodextrin
- beta
- solution
- inclusion compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 68
- 229920000858 Cyclodextrin Polymers 0.000 title claims abstract description 50
- 239000001116 FEMA 4028 Substances 0.000 title claims abstract description 44
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 title claims abstract description 44
- 235000011175 beta-cyclodextrine Nutrition 0.000 title claims abstract description 44
- 229960004853 betadex Drugs 0.000 title claims abstract description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 150000001875 compounds Chemical class 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000007787 solid Substances 0.000 claims abstract description 12
- 239000000839 emulsion Substances 0.000 claims abstract description 6
- 239000012065 filter cake Substances 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 238000000967 suction filtration Methods 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 6
- 238000001035 drying Methods 0.000 claims abstract description 5
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 18
- 240000003553 Leptospermum scoparium Species 0.000 claims description 18
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 18
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 6
- 241000220317 Rosa Species 0.000 claims description 6
- 240000005385 Jasminum sambac Species 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 238000005265 energy consumption Methods 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 230000007935 neutral effect Effects 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 241000207840 Jasminum Species 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005868 electrolysis reaction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- -1 cyclic oligosaccharide Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 150000003215 pyranoses Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3472—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/30—Hydrogen technology
- Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
Abstract
The invention discloses a method for preparing beta-cyclodextrin and essential oil inclusion compound by an alkaline electrolytic water method, which comprises the following steps: (1) dissolving the recrystallized beta-cyclodextrin in alkaline electrolytic water with the pH value of 10-12 to obtain a solution I; dissolving the essential oil in absolute ethyl alcohol to obtain a solution II; (2) dropwise adding the solution I into the solution II under stirring, and reacting in a constant-temperature water bath at 20-75 ℃ for 3-7h to obtain emulsion; adjusting the temperature to room temperature, standing for 24-48h, filtering, washing a filter cake with absolute ethyl alcohol, performing suction filtration to obtain a white solid, and drying to obtain the beta-cyclodextrin and essential oil inclusion compound. The invention introduces alkaline electrolyzed water as a solvent and a medium, provides favorable reaction conditions for inclusion reaction, and the alkaline electrolyzed water can be naturally recovered to the state of neutral water after being used, thereby being green and environment-friendly. The beta-cyclodextrin and essential oil inclusion compound has high inclusion rate and yield, and has the advantages of simple operation, low energy consumption and simple post-treatment.
Description
Technical Field
The invention belongs to the fields of beta-cyclodextrin inclusion compound synthetic chemistry, green chemistry and essential oil inclusion compound preparation technology, and particularly relates to a method for preparing beta-cyclodextrin and tea tree essential oil inclusion compounds by an alkaline electrolytic water method.
Background
Essential Oil (Tree Oil) is a volatile aromatic substance obtained by distilling root, stem and leaf of plant with steam, cold soaking or solvent extraction, and is mostly liquid at room temperature, but a few kinds are solid, and have special fragrance. Common essential oils include tea tree essential oil, jasmine essential oil, rose essential oil, and the like. Each plant essential oil has a chemical structure to determine its flavor, color, fluidity and its mode of operation with the system, and each plant essential oil has a specific set of functional characteristics. For example, the tea tree essential oil has the effects of resisting bacteria, corrosion and oxidation, is a more effective medicament than the traditional corrosion inhibitor, and has certain antiviral activity, anti-inflammatory activity and anti-tumor activity; the jasmine essential oil can relieve depression, revivify, promote self-confidence, and care and improve skin dryness; the rose essential oil has good effects of beautifying and protecting skin, can nourish interior and exterior, fade spots, promote melanin decomposition and restore skin elasticity. The essential oil has a plurality of advantages and can be widely applied to the fields of medicines, foods, daily necessities and the like.
Cyclodextrins (CD) are produced by enzymatic hydrolysis of starch. Cyclodextrin molecules are classified into alpha-cyclodextrin (alpha-CD), beta-cyclodextrin (beta-CD) and gamma-cyclodextrin (gamma-CD) according to the number of pyranoses contained. The yield of the beta-CD accounts for more than 95 percent of that of a cyclodextrin product due to the characteristics of low production cost, proper cavity structure and the like. The beta-CD is a cyclic oligosaccharide formed by connecting 7 chair-shaped D-pyranose monomers through alpha- (1,4) glycosidic bonds, and the molecular appearance is in a ring hollow cone shape with a narrow top and a wide bottom. beta-CD can be combined with a plurality of hydrophobic guest molecules due to the special ring structure of 'internal hydrophobicity and external hydrophilicity', and forms inclusion compounds through intermolecular force, van der Waals force and the like. In recent years, beta-CD has become more and more widely used in the fields of chromatographic separation, food and molecular catalysis.
The electrolyzed water is produced by direct current electrolysis of a dilute potassium chloride or sodium chloride solution in an electrolytic cell. After the electrolysis is started, under the influence of an electric field, OH-is oxidized to generate O2 and H2O in the anode region, the concentration of the OH-is gradually reduced, the solution is acidic, and acidic electrolyzed water is generated; h + is reduced in the cathode region to H2, and as the H + concentration gradually decreases, the solution becomes alkaline, producing alkaline electrolyzed water. The alkaline electrolyzed water has excellent degerming performance as multifunctional ionized water with alkaline characteristics, but no report of applying the alkaline electrolyzed water to the synthesis of beta-CD inclusion compounds exists at present.
The essential oil is greatly limited in storage and application because of its strong volatility and easy oxidation in air. To improve the stability of essential oils, masking the pungent odor of essential oils, essential oils are often prepared with β -CD as an inclusion compound. Although the utilization of essential oil is improved in the current synthetic method, the specific product stability is not reported in detail, the inclusion rate and the yield of the product are low, the reaction condition is complex, and the utilization rate of raw materials is not ideal.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a method for preparing beta-cyclodextrin and essential oil inclusion compounds by an alkaline electrolytic water method.
The technical scheme of the invention is summarized as follows:
a method for preparing beta-cyclodextrin and essential oil inclusion compound by an alkaline electrolytic water method comprises the following steps:
(1) dissolving the recrystallized beta-cyclodextrin in alkaline electrolytic water with the pH value of 10-12 to obtain a solution I; dissolving the essential oil in absolute ethyl alcohol to obtain a solution II;
(2) dropwise adding the solution I into the solution II under stirring, and reacting in a constant-temperature water bath at 20-75 ℃ for 3-7h to obtain emulsion; adjusting the temperature to room temperature, standing for 24-48h, filtering, washing a filter cake with absolute ethyl alcohol, and performing suction filtration to obtain a white solid; and (3) drying the white solid in vacuum for 4-6h to obtain the beta-cyclodextrin and essential oil inclusion compound.
Preferably, the ratio of β -cyclodextrin to alkaline electrolyzed water having a pH of 10-12 is 1g (20mL to 40 mL).
Preferably, the mass ratio of the absolute ethyl alcohol to the essential oil is 1 (1.7-5.2).
Preferably, the mass ratio of the essential oil to the beta-cyclodextrin is 1 (0.997-1.58).
The essential oil is preferably tea tree essential oil, jasmine essential oil or rose essential oil, and may be other essential oils.
The invention has the advantages that:
the invention provides a method for preparing beta-cyclodextrin and essential oil inclusion compounds by adopting green alkaline electrolyzed water, the alkaline electrolyzed water is introduced to serve as a solvent and a medium, favorable reaction conditions are provided for inclusion reaction, the alkaline electrolyzed water can be naturally recovered to a neutral water state after being used, and the method has the characteristics of green and environmental protection. The beta-cyclodextrin and essential oil inclusion compound prepared by the method has higher inclusion rate and yield which respectively reach 54.35 percent and 80.26 percent, the stability of essential oil in the essential oil inclusion compound is greatly enhanced, and meanwhile, the process has the advantages of simple operation, low energy consumption and simple post-treatment.
Drawings
FIG. 1 is an infrared spectrum of beta-CD;
FIG. 2 is an infrared spectrum of an inclusion compound of beta-cyclodextrin and tea tree essential oil;
FIG. 3 is an X-ray diffraction pattern of β -CD;
FIG. 4 is an X-ray diffraction pattern of beta-cyclodextrin and tea tree essential oil inclusion compound;
FIG. 5 is a DSC of β -CD;
FIG. 6 is a DSC chart of inclusion compound of beta-cyclodextrin and tea tree essential oil.
Detailed Description
The invention is further illustrated by the following examples, which are intended to demonstrate the preparation of the invention and which are given by way of illustration and example only and are not to be construed or construed as limiting the scope of the invention.
Example 1
A method for preparing beta-cyclodextrin and essential oil inclusion compound by an alkaline electrolytic water method comprises the following steps:
(1) dissolving 60g (0.0529mol) of recrystallized beta-cyclodextrin (beta-CD) (see fig. 1, fig. 3 and fig. 5) in 1200mL of alkaline electrolyzed water having a pH of 10 to obtain a first solution; dissolving 37.9g (0.0529mol) of tea tree essential oil in 7.3g (0.1587mol) of absolute ethyl alcohol to obtain a solution II;
(2) dropwise adding the solution I into the solution II under stirring, and reacting in a constant-temperature water bath at 20 ℃ for 7 hours to obtain emulsion; adjusting the temperature to room temperature, standing for 24h, filtering, washing a filter cake with absolute ethyl alcohol, removing unreacted tea tree essential oil and impurities, and performing suction filtration to obtain a white solid; vacuum drying the white solid for 4h to obtain beta-cyclodextrin and tea tree essential oil clathrate (see fig. 2, fig. 4 and fig. 6). The inclusion rate was 72.56%, and the yield was 87.68%.
Example 2
A method for preparing beta-cyclodextrin and essential oil inclusion compound by an alkaline electrolytic water method comprises the following steps:
(1) dissolving 50g (0.044mol) of recrystallized beta-cyclodextrin in 1500mL of alkaline electrolyzed water with pH of 11 to obtain a solution I; 44.13g (0.0616mol) of tea tree essential oil is dissolved in 17g (0.3696mol) of absolute ethyl alcohol to obtain a solution II;
(2) dropwise adding the solution I into the solution II under stirring, and reacting in a constant-temperature water bath at 55 ℃ for 5 hours to obtain emulsion; adjusting the temperature to room temperature, standing for 36h, filtering, washing a filter cake with absolute ethyl alcohol, removing unreacted tea tree essential oil and impurities, and performing suction filtration to obtain a white solid; and (3) drying the white solid in vacuum for 5 hours to obtain the beta-cyclodextrin and tea tree essential oil inclusion compound. The inclusion rate was 70.86%, and the yield was 87.98%.
In this example, a tea tree essential oil was replaced with a jasmine essential oil or a rose essential oil, and in the same manner as in this example, a beta-cyclodextrin and jasmine essential oil inclusion compound or a beta-cyclodextrin and rose essential oil inclusion compound was prepared, which had an inclusion rate and a yield similar to those of the product obtained in this example.
Example 3
A method for preparing beta-cyclodextrin and essential oil inclusion compound by an alkaline electrolytic water method comprises the following steps:
(1) dissolving 40g (0.035mol) of recrystallized beta-cyclodextrin in 1600mL of alkaline electrolytic water with pH 12 to obtain a solution I; dissolving 40.12g (0.056mol) of tea tree essential oil in 23.18g (0.504mol) of absolute ethyl alcohol to obtain a solution II;
(2) dropwise adding the solution I into the solution II under stirring, and reacting in a constant-temperature water bath at 75 ℃ for 3 hours to obtain emulsion; adjusting the temperature to room temperature, standing for 48h, filtering, washing a filter cake with absolute ethyl alcohol, removing unreacted tea tree essential oil and impurities, and performing suction filtration to obtain a white solid; and (3) drying the white solid in vacuum for 6 hours to obtain the beta-cyclodextrin and tea tree essential oil inclusion compound. The inclusion rate was 54.35%, and the yield was 80.26%.
The above description is only for illustrative purposes and is not intended to be construed as limiting the scope of the invention, and all equivalent changes, modifications, or equivalent arrangements or changes in size or dimensions that are not necessarily required to practice the invention are intended to be included therein.
Claims (5)
1. A method for preparing beta-cyclodextrin and essential oil inclusion compound by an alkaline electrolytic water method is characterized by comprising the following steps:
(1) dissolving the recrystallized beta-cyclodextrin in alkaline electrolytic water with the pH value of 10-12 to obtain a solution I; dissolving the essential oil in absolute ethyl alcohol to obtain a solution II;
(2) dropwise adding the solution I into the solution II under stirring, and reacting in a constant-temperature water bath at 20-75 ℃ for 3-7h to obtain emulsion; adjusting the temperature to room temperature, standing for 24-48h, filtering, washing a filter cake with absolute ethyl alcohol, and performing suction filtration to obtain a white solid; and (3) drying the white solid in vacuum for 4-6h to obtain the beta-cyclodextrin and essential oil inclusion compound.
2. The method as set forth in claim 1, wherein the ratio of β -cyclodextrin to alkaline electrolyzed water having a pH of 10-12 is 1g (20mL-40 mL).
3. The method as set forth in claim 1, wherein the mass ratio of the absolute ethanol to the essential oil is 1 (1.7-5.2).
4. The method as set forth in claim 1, wherein the mass ratio of the essential oil to the beta-cyclodextrin is 1 (0.997-1.58).
5. The method according to claim 1, 3 or 4, wherein the essential oil is tea tree essential oil, jasmine essential oil or rose essential oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010534051.8A CN111760033B (en) | 2020-06-12 | 2020-06-12 | Method for preparing beta-cyclodextrin and essential oil inclusion compound by alkaline electrolytic water method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010534051.8A CN111760033B (en) | 2020-06-12 | 2020-06-12 | Method for preparing beta-cyclodextrin and essential oil inclusion compound by alkaline electrolytic water method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111760033A true CN111760033A (en) | 2020-10-13 |
| CN111760033B CN111760033B (en) | 2023-04-11 |
Family
ID=72720694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010534051.8A Active CN111760033B (en) | 2020-06-12 | 2020-06-12 | Method for preparing beta-cyclodextrin and essential oil inclusion compound by alkaline electrolytic water method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111760033B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112451506A (en) * | 2020-12-10 | 2021-03-09 | 上海纳米技术及应用国家工程研究中心有限公司 | Preparation method of essential oil sustained-release capsule |
| CN113519823A (en) * | 2021-07-22 | 2021-10-22 | 西南大学 | Method for preparing konjak gel by using alkaline electrolyzed water and product prepared by method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102925290A (en) * | 2012-11-21 | 2013-02-13 | 广东省微生物研究所 | Litsea cubeba essence oil clathrate and preparation method thereof |
-
2020
- 2020-06-12 CN CN202010534051.8A patent/CN111760033B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102925290A (en) * | 2012-11-21 | 2013-02-13 | 广东省微生物研究所 | Litsea cubeba essence oil clathrate and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 周衡刚 等: "茶树油β-环糊精包合物的制备工艺研究", 《广东化工》 * |
| 李夏阳: "磺丙基醚-β-环糊精衍生物新型合成工艺", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112451506A (en) * | 2020-12-10 | 2021-03-09 | 上海纳米技术及应用国家工程研究中心有限公司 | Preparation method of essential oil sustained-release capsule |
| CN113519823A (en) * | 2021-07-22 | 2021-10-22 | 西南大学 | Method for preparing konjak gel by using alkaline electrolyzed water and product prepared by method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111760033B (en) | 2023-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111760033B (en) | Method for preparing beta-cyclodextrin and essential oil inclusion compound by alkaline electrolytic water method | |
| CN101974110B (en) | Preparation method of water-soluble ferrocene supramolecular inclusion compound | |
| CN103842555A (en) | Method for producing vanillin by electrochemically oxidizing aqueous lignin solutions or suspensions | |
| CN105254770A (en) | Preparing method for dialdehyde nano-crystalline cellulose | |
| CN103224968A (en) | Method for preparing neohesperidin by enzymic method | |
| CN101914595B (en) | Method for synthesizing ferulic acid glycolipid derivatives by enzymatic method | |
| CN103695520A (en) | Method for recycling immobilized cell and cyclodextrin during transformation of cortisone acetate | |
| CN110627761A (en) | Method for synthesizing myricetin | |
| CN105441521A (en) | Synthetic method of vitamin A palmitate | |
| Röper et al. | New carbohydrate derivatives from biotechnical and chemical processes | |
| CN100365008C (en) | Process for preparing red alga oligose | |
| CN111394406B (en) | Preparation method of gamma-cyclodextrin | |
| CN104603329A (en) | Method for producing vanillin | |
| CN101838187B (en) | Method for preparing benzaldehyde by using cyclodextrin polymer to catalyze oxidation of cinnamic aldehyde or cinnamon oil | |
| JP2012528903A (en) | Post extraction method for higher order acyl group gellan gum | |
| CN105087707B (en) | A kind of method using lipase-catalyzed synthesis dihydromyricetin monoesters compound | |
| CN101121643B (en) | Method for preparing hexahydric alcohol | |
| CN106540748A (en) | The preparation method of polythiophene tin dioxide composite material | |
| CN102093184B (en) | Method for preparing benzaldehyde by performing catalytic oxidation on cinnamyl aldehyde or cinnamon oil and special catalyst thereof | |
| CN101117641B (en) | Method for preparing secoisolariciresinol diglucoside | |
| CN111394407B (en) | Preparation method of gamma-cyclodextrin | |
| CN104630305A (en) | Production method of gamma-cyclodextrin | |
| CN107119085A (en) | A kind of method that naringenin is prepared based on aspergillus niger cell catalysis aurantiin hydrolysis | |
| CN103695521B (en) | The circulation utilization method of cortisone acetate living things catalysis cyclodextrin medium | |
| CN112898245A (en) | Method for synthesizing 5-hydroxymethylfurfural |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |